questionsmedicales.fr
Maladies du système immunitaire
Maladies auto-immunes
Maladie de Basedow
Ophtalmopathie basedowienne
Ophtalmopathie basedowienne : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Ophtalmopathie
Maladie de Basedow
Thyroïdite
Imagerie par résonance magnétique
Échographie
Thyroïde
Exophtalmie
Diplopie
Paupière
Hormones thyroïdiennes
Anticorps
Thyroïde
Diagnostic différentiel
Exophtalmie
Maladies oculaires
Symptômes
5
Exophtalmie
Sécheresse oculaire
Douleur oculaire
Diplopie
Muscles oculaires
Vision
Vision
Vision floue
Troubles visuels
Paupières
Inflammation
Gonflement
Symptômes
Variabilité
Maladie
Prévention
5
Prévention
Maladie de Basedow
Thyroïde
Tabagisme
Risque
Symptômes
Stress
Gestion du stress
Santé
Examens médicaux
Détection précoce
Santé oculaire
Alimentation
Santé thyroïdienne
Santé oculaire
Traitements
5
Corticostéroïdes
Radiothérapie
Chirurgie
Corticostéroïdes
Inflammation
Symptômes
Chirurgie
Exophtalmie
Vision
Radiothérapie
Tissus orbitaires
Inflammation
Larmes artificielles
Lunettes prismatiques
Traitements non médicamenteux
Complications
5
Complications
Perte de vision
Nerfs optiques
Perte de vision
Récupération
Gravité
Esthétique
Exophtalmie
Paupières
Nerfs optiques
Inflammation
Vision
Complications
Suivi médical
Traitement
Facteurs de risque
5
Facteurs de risque
Hyperthyroïdie
Antécédents familiaux
Antécédents familiaux
Maladies thyroïdiennes
Risque
Stress
Facteurs de risque
Symptômes
Femmes
Risque
Ophtalmopathie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ophtalmopathie basedowienne : Questions médicales les plus fréquentes",
"headline": "Ophtalmopathie basedowienne : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ophtalmopathie basedowienne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-26",
"dateModified": "2025-03-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ophtalmopathie basedowienne"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladie de Basedow",
"url": "https://questionsmedicales.fr/mesh/D006111",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Basedow",
"code": {
"@type": "MedicalCode",
"code": "D006111",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.555"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Ophtalmopathie basedowienne",
"alternateName": "Graves Ophthalmopathy",
"code": {
"@type": "MedicalCode",
"code": "D049970",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kubra Serbest Ceylanoglu",
"url": "https://questionsmedicales.fr/author/Kubra%20Serbest%20Ceylanoglu",
"affiliation": {
"@type": "Organization",
"name": "University of Health Sciences, Ulucanlar Eye Education and Research Hospital, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Emine Malkoc Sen",
"url": "https://questionsmedicales.fr/author/Emine%20Malkoc%20Sen",
"affiliation": {
"@type": "Organization",
"name": "University of Health Sciences, Ulucanlar Eye Education and Research Hospital, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Xin Wang",
"url": "https://questionsmedicales.fr/author/Xin%20Wang",
"affiliation": {
"@type": "Organization",
"name": "School of Basic Medical Science, Special Key Laboratory of Ocular Diseases of Guizhou Province, Zunyi Medical University, Zunyi, 563000, China."
}
},
{
"@type": "Person",
"name": "Poupak Fallahi",
"url": "https://questionsmedicales.fr/author/Poupak%20Fallahi",
"affiliation": {
"@type": "Organization",
"name": "Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy."
}
},
{
"@type": "Person",
"name": "Alessandro Antonelli",
"url": "https://questionsmedicales.fr/author/Alessandro%20Antonelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Low-grade appendiceal mucinous neoplasms: Histomorphological spectrum in a tertiary care hospital.",
"datePublished": "2023-09-21",
"url": "https://questionsmedicales.fr/article/39023592",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/jcrt.jcrt_149_22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Navigating the diagnostic gray zone: a challenging case of pancreatic high-grade neuroendocrine neoplasm.",
"datePublished": "2024-09-12",
"url": "https://questionsmedicales.fr/article/39267076",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13000-024-01546-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.",
"datePublished": "2024-05-02",
"url": "https://questionsmedicales.fr/article/38693435",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00262-024-03704-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Experimenting with ASL-based arterialized cerebral blood volume as a novel imaging biomarker in grading glial neoplasms.",
"datePublished": "2023-08-07",
"url": "https://questionsmedicales.fr/article/37548164",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/19714009231193163"
}
},
{
"@type": "ScholarlyArticle",
"name": "CT findings and clinical effects of high grade pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms.",
"datePublished": "2024-04-29",
"url": "https://questionsmedicales.fr/article/38683769",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0298278"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladie de Basedow",
"item": "https://questionsmedicales.fr/mesh/D006111"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ophtalmopathie basedowienne",
"item": "https://questionsmedicales.fr/mesh/D049970"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ophtalmopathie basedowienne - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ophtalmopathie basedowienne",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ophtalmopathie basedowienne",
"description": "Comment diagnostiquer l'ophtalmopathie de Basedow ?\nQuels examens sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent cette maladie ?\nLes tests sanguins sont-ils nécessaires ?\nPeut-on confondre cette maladie avec d'autres ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Neoplasm+Grading#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ophtalmopathie basedowienne",
"description": "Quels sont les symptômes courants ?\nLa diplopie est-elle fréquente ?\nY a-t-il des changements dans la vision ?\nComment se manifeste l'inflammation des paupières ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Neoplasm+Grading#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ophtalmopathie basedowienne",
"description": "Peut-on prévenir l'ophtalmopathie de Basedow ?\nLe tabagisme influence-t-il la maladie ?\nComment gérer le stress pour prévenir la maladie ?\nLes examens réguliers sont-ils importants ?\nUne alimentation saine peut-elle aider ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Neoplasm+Grading#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ophtalmopathie basedowienne",
"description": "Quels traitements sont disponibles ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand la chirurgie est-elle nécessaire ?\nLa radiothérapie est-elle courante ?\nY a-t-il des traitements non médicamenteux ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Neoplasm+Grading#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ophtalmopathie basedowienne",
"description": "Quelles sont les complications possibles ?\nLa perte de vision est-elle réversible ?\nQuels problèmes esthétiques peuvent survenir ?\nLes nerfs optiques peuvent-ils être affectés ?\nY a-t-il des risques de complications après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Neoplasm+Grading#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ophtalmopathie basedowienne",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?\nLes femmes sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D049970?mesh_terms=Neoplasm+Grading#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'ophtalmopathie de Basedow ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'imagerie et des tests sanguins pour évaluer la fonction thyroïdienne."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les examens incluent l'échographie oculaire, l'IRM et les tests de la fonction thyroïdienne."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent cette maladie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent l'exophtalmie, la diplopie, et des modifications de la paupière."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils nécessaires ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de mesurer les niveaux d'hormones thyroïdiennes et d'anticorps."
}
},
{
"@type": "Question",
"name": "Peut-on confondre cette maladie avec d'autres ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres causes d'exophtalmie, nécessitant un diagnostic différentiel."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'exophtalmie, la sécheresse oculaire, et des douleurs oculaires."
}
},
{
"@type": "Question",
"name": "La diplopie est-elle fréquente ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la diplopie est un symptôme courant, causée par l'atteinte des muscles oculaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des changements dans la vision ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements visuels peuvent survenir, y compris une vision floue ou double."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'inflammation des paupières ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inflammation peut entraîner un gonflement, une rougeur et une rétraction des paupières."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la combinaison des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'ophtalmopathie de Basedow ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais contrôler la thyroïde peut aider."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la maladie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme aggrave les symptômes et augmente le risque d'ophtalmopathie."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour prévenir la maladie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion du stress peut aider à réduire les poussées de la maladie et améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers permettent de détecter précocement les signes de la maladie."
}
},
{
"@type": "Question",
"name": "Une alimentation saine peut-elle aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé thyroïdienne et oculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les corticostéroïdes, la radiothérapie et la chirurgie dans les cas graves."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent l'inflammation et améliorent les symptômes oculaires."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle nécessaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée pour corriger l'exophtalmie sévère ou les problèmes de vision."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle courante ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour traiter l'inflammation sévère des tissus orbitaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements non médicamenteux incluent des larmes artificielles et des lunettes prismatiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, l'atteinte des nerfs optiques et des problèmes esthétiques."
}
},
{
"@type": "Question",
"name": "La perte de vision est-elle réversible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité de l'atteinte; certaines pertes peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels problèmes esthétiques peuvent survenir ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes esthétiques incluent l'exophtalmie et des modifications des paupières."
}
},
{
"@type": "Question",
"name": "Les nerfs optiques peuvent-ils être affectés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inflammation peut entraîner une compression des nerfs optiques, affectant la vision."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications après traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications peuvent survenir même après un traitement, nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hyperthyroïdie, le tabagisme et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente généralement avec l'âge, surtout chez les femmes de 30 à 50 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de maladies thyroïdiennes augmente le risque d'ophtalmopathie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut déclencher ou aggraver les symptômes de l'ophtalmopathie."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus souvent touchées par l'ophtalmopathie de Basedow que les hommes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 23/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
University of Health Sciences, Ulucanlar Eye Education and Research Hospital, Ankara, Turkey.
Publications dans "Ophtalmopathie basedowienne" :
4 publications dans cette catégorie
Affiliations :
University of Health Sciences, Ulucanlar Eye Education and Research Hospital, Ankara, Turkey.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
School of Basic Medical Science, Special Key Laboratory of Ocular Diseases of Guizhou Province, Zunyi Medical University, Zunyi, 563000, China.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Endocrinology and Metabolism, Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China.
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Biomedical Commercialization Center, Taipei Medical University, Taipei 11031, Taiwan.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
School of Medicine, National Yang Ming University, Taipei 11221, Taiwan.
School of Medicine, National Yang Ming Chiao Tung University, Hsinchu 30010, Taiwan.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, National Taiwan University Hospital, Taipei 100225, Taiwan.
Publications dans "Ophtalmopathie basedowienne" :
3 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, National Taiwan University Hospital, Taipei 100225, Taiwan.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.
Laboratory of Biochemistry and Clinical Chemistry at the Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Chair and Department of Biochemistry, First Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology, Medical Center for Postgraduate Education, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology, Medical Center for Postgraduate Education, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Chair and Department of Biochemistry, First Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland.
Department of Otolaryngology, Medical Center for Postgraduate Education, Warsaw, Poland.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Third Xiangya Hospital, Central South University, Yuelu District, 138 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China.
Publications dans "Ophtalmopathie basedowienne" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Third Xiangya Hospital, Central South University, Yuelu District, 138 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China. weixiong420@csu.edu.cn.
Publications dans "Ophtalmopathie basedowienne" :
Low-grade appendiceal mucinous neoplasms (LAMNs) are benign non-invasive epithelial proliferations of the appendix. These usually present clinically as mucoceles and these rarely exceed 2 cm in diamet...
A retrospective study was conducted over a period of three years and all cases of appendectomies were studied. Twelve cases of LAMN were identified, which is a diagnostic dilemma for the pathologists ...
LAMN was identified based on the histopathological features. Out of the 12 cases, 9 were classified as LAMN and 3 as appendiceal neoplasm with PMP. There was villous or flat proliferation of epithelia...
LAMNs are rare neoplasms of the appendix, with clinical presentation similar to acute appendicitis. Mucinous collections within the appendiceal wall should be extensively searched for mucosal changes ...
Grade 3 neuroendocrine tumor (G3 PanNET) and poorly differentiated neuroendocrine carcinoma (PanNEC) of the pancreas are considered distinct entities from a biological and prognostic perspective but m...
A 52-year-old female presented with a pancreatic body mass and liver lesions. Initial biopsies showed variable lower- and higher-grade morphologies and modestly elevated Ki67 proliferation index up to...
This case highlights the diagnostic complexities of distinguishing G3 PanNET and PanNEC even with the support of ancillary immunohistochemical and molecular studies. In addition, such cases raise the ...
Advancements in immunotherapeutic approaches only had a modest impact on the therapy of lung neuroendocrine neoplasms (LNENs). Our multicenter study aimed to investigate the expression patterns of nov...
The expressions of V-domain Ig suppressor of T cell activation (VISTA), OX40L, Glucocorticoid-induced TNF receptor (GITR), and T cell immunoglobulin and mucin domain 3 (TIM3) proteins were measured by...
Tumor cell TIM3 expression was the highest in ACs (p < 0.001), whereas elevated tumor cell GITR levels were characteristic for both ACs and SCLCs (p < 0.001 and p = 0.011, respectively). OX40L express...
LNEN subtypes have characteristic and widely divergent VISTA, OX40L, GITR, and TIM3 protein expressions. By shedding light on the different expression patterns of these immunotherapy targets, the curr...
Perfusion imaging is one of the methods used to grade glial neoplasms, and in this study we evaluated the role of ASL perfusion in grading brain glioma....
The aim is to evaluate the role of arterialized cerebral blood volume (aCBV) of multi-delay ASL perfusion for grading glial neoplasm....
This study is a prospective observational study of 56 patients with glial neoplasms of the brain who underwent surgery, and only cases with positive diagnosis of glioma are included to evaluate the no...
In the study, ASL-derived normalized aCBV (naCBV) and T2*DSC-derived normalized CBV (nCBV) are showing very high correlation (Pearson's correlation coefficient value of 0.94) in grading glial neoplasm...
This study is one of its kind to the best of our knowledge where multi-delay ASL perfusion-derived aCBV is used as a novel imaging biomarker for grading glial neoplasms, and it has shown high statisti...
To investigate the common CT findings of high-grade (HG) PanIN and clinical effects in the remnant pancreas in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas....
Two hundred fifty-one patients with surgically confirmed IPMNs (118 malignant [invasive carcinoma/high-grade dysplasia] and 133 benign [low-grade dysplasia]) were retrospectively enrolled. The grade o...
PanIN grade showed a significant association with IPMN grade (p = 0.012). Enhancing mural nodules ≥5 mm, abrupt main pancreatic duct (MPD) changes with distal pancreatic atrophy, increased mural nodul...
CT can be useful for predicting HG PanIN using common features, such as abrupt MPD changes and mural nodules. In HG PanIN, extra caution is needed to monitor postoperative recurrence during follow-up....
This study aims to determine whether Pokemon regulates Bim activity in colorectal carcinoma (CRC) carcinogenesis....
Clinical tissue samples were analyzed to detect the expression and clinicopathological significance of Pokemon and Bim in CRC. Proliferation, apoptosis, and invasion assays were conducted to identify ...
Immunohistochemical analysis of 80 samples of colorectal epithelia (CRE), 80 cases of colorectal adenoma (CRA), and 160 of CRC samples revealed protein expression rates of 23.8%, 38.8%, and 70.6% for ...
These findings suggest that Pokemon inhibits Bim transcription, thereby promoting CRC proliferation, resistance to apoptosis, invasion, and advancing histological grade and Dukes staging. Pokemon knoc...
High-grade neuroendocrine neoplasms are a rare disease entity and account for approximately 10% of all neuroendocrine neoplasms. Because of their rarity, there is an overall lack of prospectively coll...
Low-grade appendiceal mucinous neoplasms (LAMN) are very rare, accounting for approximately 0.2%-0.5% of gastrointestinal tumors. We conducted a multicenter retrospective study to explore the impact o...
We retrospectively analyzed the clinicopathological data of 91 LAMN perforation patients from 9 teaching hospitals over a 10-year period, and divided them into HIPEC group and non-HIPEC group based on...
Of the 91 patients with LAMN, 52 were in the HIPEC group and 39 in the non-HIPEC group. The Kaplan-Meier method predicted that 52 patients in the HIPEC group had 5- and 10-year overall survival rates ...
This study shows that surgery combined with HIPEC can significantly improve 5-year and 10-year overall survival rates and relapse-free survival rates of LAMN perforation patients, without affecting th...
The prognosis of patients with advanced high-grade (G3) digestive neuroendocrine neoplasms (NENs) is rather poor. The addition of immune checkpoint inhibition to platinum-based chemotherapy may improv...
Magnetic resonance imaging (MRI)-targeted prostate biopsy has become an increasingly common method of diagnosing prostate cancer. A previous study from our institution demonstrated that the biopsy glo...
We conducted a retrospective review of radical prostatectomy specimens with prior MRI-targeted biopsies from our institution between 2016 and 2020. Separate gGG and hGG were assigned to each MRI-targe...
Of the 489 lesions with MRI-targeted biopsies, 82 (17%) differed in gGG versus hGG. The gGG of 46 (56%), 33 (40%), and 3 (4%) lesions were unchanged, upgraded, and downgraded at radical prostatectomy,...
When gGG and hGG differ, gGG method more accurately predicts the RPGG than hGG, particularly in GG2 and GG3 lesions which comprised the majority of targeted lesions....